This activity was planned with a goal to enable participants to learn best practices when prescribing bempedoic acid to the statin intolerant patient. This activity is part of the Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant supported by Esperion.
Important Dates: Date of Release: December 8, 2023Term of Approval/Date of Expiration: December 8, 2024 Learner Objectives: Upon completion of this activity, you should be able to:
Describe safety, efficacy, and long-term CV outcomes data of bempedoic acid based on clinical trial data.
Identify patients that would benefit from bempedoic acid and how to integrate this into practice.
Develop a treatment plan for the statin intolerant patient including the use of bempedoic acid.
Acknowledgement Educational grant support provided by: Esperion.
Faculty:Erin D. Michos, MD, MHS, FACC